ENMD-1198

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameENMD-1198
Drug Alias NameENMD-1198
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitorsTubulin inhibitorsNuclear factor NF-kappa-B complex inhibitors +[4] 
TargetsNuclear factor NF-kappa-B complexSignal transducer and activator of transcription 3Hypoxia-inducible factor 1 alpha +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCasi Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCasi Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A